对于抑郁症的theta爆发刺激:一个系统的审查和网络和对联的元分析
Taro Kishi1, Toshikazu Ikuta2, Kenji Sakuma3
1Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, 470-1192, Japan. tarok@fujita-hu.ac.jp.
Molecular psychiatry
|June 6, 2024
概括
甲爆刺激 (TBS) 为抑郁症治疗提供了一种更有效的替代方法,而不是重复性跨磁刺激 (rTMS). 某些TBS协议,特别是右背侧前额皮层上的连续TBS (cTBS) 以及左DLPFC上的间歇性TBS (iTBS),以及左DLPFC上的iTBS,显示出有利的风险效益概况.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 临床试验 临床试验
背景情况:
- 重复性横磁性刺激 (rTMS) 是抑郁症的常规治疗方法.
- 甲爆刺激 (TBS) 是一种更有效的rTMS形式,可以更快地传递刺激.
- 针对抑郁症,已经提出了各种加速TBS协议 (连续TBS[cTBS]和间歇性TBS[iTBS]).
研究的目的:
- 系统地审查和对随机对照试验 (RCT) 进行网络元分析,评估抑郁症的TBS协议.
- 为了确定哪些TBS协议为患有抑郁症的人提供最有利的风险效益平衡.
- 为了比较疗效 (反应率,症状改善,缓解) 和安全性 (停止治疗,躁狂转换,副作用) 与假药治疗.
主要方法:
- 系统审查和随机效应模型网络元分析.
- 包括23个RCT (n=960) 评估六个TBS协议:cTBS (右背侧前额叶皮层[R-DLPFC]),cTBS (R-DLPFC) + iTBS (左DLPFC [L-DLPFC]),iTBS (L-DLPFC),iTBS (L-DLPFC) + iTBS (R-DLPFC),iTBS (左背中间前额叶皮层) + iTBS (右背中间前额叶皮层) 和iTBS (头骨叶).
- 评估的结果包括应答率,抑郁症症状改善,缓解率,因任何原因停药,转变为躁狂,头痛/不适.
主要成果:
- 与假药相比,cTBS (R-DLPFC) + iTBS (L-DLPFC),iTBS (L-DLPFC) 和iTBS (叶) 的反应率明显更高.
- 在改善抑郁症状方面,cTBS (R-DLPFC) + iTBS (L-DLPFC) 和 iTBS (L-DLPFC) 的效果更为优异.
- iTBS (L-DLPFC) 显示了更高的缓解率. 在TBS协议和假药之间没有观察到停药率,躁狂转换或副作用的显著差异.
结论:
- 结合cTBS (R-DLPFC) + iTBS (L-DLPFC) 和iTBS (L-DLPFC) 协议的结合方案在治疗抑郁症方面表现出有利的风险效益平衡.
- 这些特定的TBS协议在不影响安全的情况下,在响应,症状改善和缓解率方面提供了更高的疗效.
- TBS代表了一种有前途且有效的神经调节技术,用于严重抑郁症管理.
相关概念视频
Electroconvulsive Therapy
33
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
33
Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
Depression: Overview
238
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
238


